Hedonic Eating Is Associated with Increased Peripheral Levels of Ghrelin and the Endocannabinoid 2-Arachidonoyl-Glycerol in Healthy Humans: A Pilot Study

Murphy, 2006, Gut hormones and the regulation of energy homeostasis., Nature, 444, 854, 10.1038/nature05484

Schwartz, 2000, Central nervous system control of food intake., Nature, 404, 661, 10.1038/35007534

Lowe, 2007, Hedonic hunger: a new dimension of appetite?, Physiol Behav, 91, 432, 10.1016/j.physbeh.2007.04.006

Finlayson, 2007, Liking vs. wanting food: importance for human appetite control and weight regulation., Neurosci Biobehav Rev, 31, 987, 10.1016/j.neubiorev.2007.03.004

Lutter, 2009, Homeostatic and hedonic signals interact in the regulation of food intake., J Nutr, 139, 629, 10.3945/jn.108.097618

Jerlhag, 2007, Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens., Addict Biol, 12, 6, 10.1111/j.1369-1600.2006.00041.x

Di Marzo, 2009, The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation., Int J Obes (Lond), 33, 18, 10.1038/ijo.2009.67

First, 1996, Structured clinical interview for Axis I DSM-IV disorders-non-patient ed (SCID-I/NP, version 2.0)

Monteleone, 2005, Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa., Neuropsychopharmacology, 30, 1216, 10.1038/sj.npp.1300695

Annuzzi, 2010, Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients., Lipids Health Dis, 9, 43, 10.1186/1476-511X-9-43

Dixon, 1985, BMDP statistical software

Di Marzo, 2001, Leptin-regulated endocannabinoids are involved in maintaining food intake., Nature, 410, 822, 10.1038/35071088

Simonian, 2005, Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release., Neurogastroenterol Motil, 17, 348, 10.1111/j.1365-2982.2004.00634.x

Cummings, 2001, A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans., Diabetes, 50, 1714, 10.2337/diabetes.50.8.1714

Malik, 2008, Ghrelin modulates brain activity in areas that control appetitive behavior., Cell Metab, 7, 400, 10.1016/j.cmet.2008.03.007

Berridge, 1998, What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?, Brain Res Brain Res Rev, 28, 309, 10.1016/S0165-0173(98)00019-8

Melis, 2007, The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food., Neurosci Lett, 419, 231, 10.1016/j.neulet.2007.04.012

Simiand, 1998, SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset., Behav Pharmacol, 9, 179

Izzo, 2009, 2009 Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding., Br J Pharmacol, 158, 451, 10.1111/j.1476-5381.2009.00183.x

DiPatrizio, 2011, Endocannabinoid signal in the gut controls dietary fat intake., Proc Natl Acad Sci USA, 108, 12904, 10.1073/pnas.1104675108

Di Marzo, 2011, Endocannabinoids: an appetite for fat., Proc Natl Acad Sci USA, 108, 12567, 10.1073/pnas.1109567108

Caraceni, 2010, Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis., Liver Int, 30, 816, 10.1111/j.1478-3231.2009.02137.x

Centonze, 2008, The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases., Curr Pharm Des, 14, 2370, 10.2174/138161208785740018

Kola, 2008, The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system., PloS One, 3, e1797, 10.1371/journal.pone.0001797

Cani, 2004, Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide., Br J Nutr, 92, 757, 10.1079/BJN20041256

Gatta-Cherifi, 2011, Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity, Int J Obes (Lond)

Mascia, 2011, Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors., Biol Psychiatry, 69, 633, 10.1016/j.biopsych.2010.07.009

Matias, 2006, Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia., J Clin Endocrinol Metab, 91, 3171, 10.1210/jc.2005-2679

Matias, 2007, Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells., Br J Pharmacol, 152, 676, 10.1038/sj.bjp.0707424

Di Marzo, 2009, Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects., Eur J Endocrinol, 161, 715, 10.1530/EJE-09-0643